News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    

Biotech/Pharma - Investor
AmpliPhi Biosciences Corporation (APHB) Cleared To Submit Listing Application To NYSE MKT 8/4/2015
Lumenis (LUME) Announces Results Of Special Shareholders' Meeting 8/4/2015
Celgene (CELG) Prices $8 Billion Of Senior Unsecured Notes 8/4/2015
Genocea Biosciences Announces Closing Of $50 Million Public Offering Of Common Stock 8/4/2015
Mettler-Toledo (MTD) Announces New Process Chemistry And Scale-up Online Seminar 8/4/2015
Amarantus BioSciences, Inc. Announces Adjournment Of Annual Meeting 8/4/2015
Intec Pharma Ltd. Announces Pricing of U.S. Initial Public Offering 8/4/2015
Integra LifeSciences (IART) Announces Proposed Public Offering Of Common Stock 8/4/2015
Quotient Limited (QTNTU) Expands Existing Term Credit Facility With MidCap Financial to $50 Million 8/4/2015
Corium International, Inc. Announces Proposed Public Offering of Common Stock 8/4/2015
HEALTHSOUTH Announces Private Offering Of Senior Notes 8/4/2015
AcelRx (ACRX) Provides Business Update And Reports Second Quarter And Six Months 2015 Financial Results 8/4/2015
Emdeon Corporation (HLTH) Announces Offering Of Its Senior Notes Due 2021 8/4/2015
Boston Scientific (BSX) Announces Equity Investment And Sales Cooperation Agreement With Preventice Solutions 8/4/2015
PTC Therapeutics (PTCT) Reports Second Quarter 2015 Financial Results And Provides Corporate Update 8/3/2015
Horizon Pharma (HZNP) Commences Process To Request A Special Meeting Of Depomed (DEPO) Shareholders 8/3/2015
Tauriga Sciences Inc. (TAUG) Granted 7 Day Extension By OTC Markets To Maintain Listing On OTCQB Exchange 8/3/2015
Sevion Therapeutics, Inc. Announces Close Of Private Placement Financing For Gross Proceeds Of Approximately $6.55 Million 8/3/2015
Welcome To The Annual General Meeting Of Shareholders Of Elekta AB (SE:EKTAB) 8/3/2015
Jaguar Holding Company II And Pharmaceutical Product Development, LLC Announce $1,125 Million Senior Notes Offering 8/3/2015
Celgene (CELG) Announces Offering Of Senior Unsecured Notes 8/3/2015
Bacterin Closes Offering Of $65 Million Of 6.00% Convertible Senior Notes 8/3/2015
Arbutus Biopharma (TKMR) To Ring The Nasdaq Stock Market Opening Bell 8/3/2015
IDEXX Laboratories, Inc. (IDXX) To Host 2015 Analyst Day 8/3/2015
Egalet Announces Closing Of Public Offering Of Common Stock And Exercise In Full Of Underwriters' Option To Purchase Additional Shares 8/3/2015
China Cord Blood Corporation Files Its Annual Report On Form 20-F 8/3/2015
Tianyin Pharmaceutical Co, Inc. Provides Update Regarding Non-Compliance With NYSE MKT Continued Listing Requirements 7/31/2015
Number Of Shares And Votes In Orexo AB (ORXOF) 7/31/2015
Change In The Total Number Of Shares And Votes In Recipharm AB 7/31/2015
Change In Number Of Shares And Votes In Moberg Pharma AB (Formerly known as Moberg Derma) 7/31/2015
Change Of The Number Of Shares And Votes In Karo Bio AB 7/31/2015
Newly Appointed Acting CEO Outlines Immediate Plans For Novogen Limited (NVGN) 7/31/2015
Quintiles (Q) Announces Launch Of Secondary Public Offering Of Common Stock 7/31/2015
Quintiles (Q) Announces Pricing Of Secondary Public Offering 7/31/2015
Cryo-Cell International (CCEL), Cord Blood Banking Company, Announces Final Results Of Its Tender Offer 7/31/2015
Nanosphere, Inc. Announces Amendment to $30 Million Term Loan Facility, Release of Q2 2015 Results and Conference Call and Schedules 2015 Annual Meeting of Stockholders 7/31/2015
EyeGate Pharma Announces Pricing Of $10,000,000 Public Offering Of Common Stock And Warrants 7/31/2015
AMAG (AMAG) Prices Public Offering Of $201 Million Of Common Stock 7/31/2015
GlaxoSmithKline (GSK) CEO Confident Investors Will Be Pleased With Pipeline on Nov. R&D Day 7/30/2015
Admedus Announcement To The Australian Stock Exchange 7/30/2015
Teleflex Incorporated (TFX) Announces Quarterly Dividend 7/30/2015
Baxter International (BAX) Declares Quarterly Dividend 7/30/2015
McKesson Corporation Declares Quarterly Dividend July 29, 2015 7/30/2015
Inotek Pharmaceuticals Corporation Announces Conversion Of $21 Million Principal Amount Of 5.0% Convertible Senior Notes Due 2020 7/30/2015
Genocea Biosciences Announces Pricing Of $50 Million Public Offering 7/30/2015
Nasdaq Welcomes vTv Therapeutics Tto The Nasdaq Stock Market 7/30/2015
KaloBios Pharmaceuticals, Inc. (KBIO) Regains Compliance With NASDAQ Minimum Bid Price Requirement 7/30/2015
Pulmatrix To Webcast Investor Presentation And Provide Update On Pipeline Of Inhaled Therapeutics August 6th 7/30/2015
SANUWAVE Shareholders Approve Proposal To Amend Articles Of Incorporation 7/30/2015
Perseon Announces Pricing Of $5.2 Million Public Offering And Listing Of Warrants On NASDAQ 7/30/2015
Cara Therapeutics, Inc. (CARA) Announces Pricing Of Its Public Offering Of Common Stocks 7/30/2015
Zealand Pharma  (ZEAL.CO) Release: Major Shareholder Announcement 7/30/2015
Zogenix (ZGNX) Prices Public Offering Of Common Stock 7/30/2015
AMAG (AMAG) Announces Proposed Public Offering Of $200 Million Of Common Stock 7/30/2015
Biogen (BIIB) Chairman Reassures Investors With $3 Million Stock Buy 7/29/2015
BioPharm Executive: Why Some Drugmakers May See Their Profits Slashed 7/29/2015
Amgen (AMGN) Announces 2015 Third Quarter Dividend 7/29/2015
McKesson Corporation Announces Preliminary Voting Results From 2015 Annual Stockholder Meeting 7/29/2015
Corbus Announces Call Notice For Exercise Of Warrants 7/29/2015
Baxalta Board Of Directors Declares Inaugural Dividend; Approves $1 Billion Share Repurchase Authorization 7/29/2015
Neos Therapeutics Announces Closing Of Initial Public Offering And Exercise Of Underwriters’ Over-Allotment Option 7/29/2015
Becton, Dickinson and Company (BDX) Board Declares Dividend 7/29/2015
Sanofi Genzyme (SNY) Launches Fifth Annual Patient Advocacy Leadership (PAL) Awards Program 7/29/2015
XlerateHealth Accelerator Announces Incoming Third Cohort 7/29/2015
Egalet Announces Pricing Of Public Offering Of Common Stock 7/29/2015
Tauriga Sciences Inc. (TAUG) Stockholders Approve Increase In Authorized Common Stock 7/29/2015
Radius Health (RDUS) Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriters' Option To Purchase Additional Shares 7/29/2015
MannKind Corporation (MNKD) Announces Stock And Note Exchange Agreements With Holders Of Outstanding 5.75% Senior Convertible Notes 7/29/2015
Zogenix (ZGNX) Announces Proposed Public Offering Of 3,800,000 Shares Of Common Stock 7/29/2015
Tissue Therapies Change In Strategy And Development Of Vitrogro As A Pharmaceutical Worldwide 7/28/2015
ESSA Pharma To Commence Trading On The Toronto Stock Exchange 7/28/2015
Egalet Announces Proposed Public Offering Of Common Stock 7/28/2015
Mylan (MYL) Announces Meeting Date And Record Date Of Extraordinary General Meeting Of Shareholders 7/28/2015
Quest PharmaTech Inc. Closes $1,000,000 Private Placement 7/28/2015
DelMar Pharmaceuticals Announces Financing Update And Initial Subscriptions Of $2.0 Million In Registered Direct Offering 7/28/2015
Dynavax Technologies Corporation (DVAX) Announces Exercise In Full Of Over-Allotment Option And Completion Of Public Offering Of Common Stock 7/28/2015
Anatara Lifesciences Closes Heavily Subscribed Share Purchase Plan 7/28/2015
Cara Therapeutics, Inc. (CARA) Announces Proposed Offering Of Common Stock 7/28/2015
Bacterin Prices $65 Million Of 6.00% Convertible Senior Notes 7/28/2015
ICON Shareholders Vote In Favour Of All Resolutions At Its Annual General Meeting 7/27/2015
Hemispherx Biopharma (HEB) To Host Stockholder Open House At Manufacturing And Research Facility In New Jersey 7/27/2015
BioMarin (BMRN) Joins The NASDAQ-100 Index 7/27/2015
Paratek Pharmaceuticals, Inc. Announces Termination Of Tax Benefit Preservation Plan 7/27/2015
Amyris, Inc. Signing Of Agreements For Conversion And Restructuring Of Approximately $175 Million Of Convertible Debt And $25 Million Private Placement 7/27/2015
PerkinElmer (PKI) Board Declares Quarterly Dividend 7/24/2015
Exelixis (EXEL) Prices Public Offering Of Common Stock 7/24/2015
Deutsche Biotech Innovativ AG: AGM Approves Bonus Shares And Capital Increase 7/24/2015
Biogenerator Makes Investment In Confluence Life Sciences 7/24/2015
CytRx Corporation (CYTR) Announces Closing Of Public Offering Of Common Stock, Including Full Exercise Of Underwriters' Option To Purchase Additional Shares 7/24/2015
Vista Partners Initiates Coverage On Immune Pharmaceuticals, Inc. (NasdaqCM: IMNP); $6.00 Price Target 7/24/2015
CryoPort, Inc. Announces Pricing Of Public Offering Of Units And Listing On NASDAQ 7/24/2015
ViewRay Completes Alternative Public Offering, Raises $26.7 Million 7/24/2015
Relypsa (RLYP) Announces New Employment Inducement Grants 7/24/2015
Cancer Genetics, Inc. (CGIX) Announced Today That It Has Suspended Its Activity On The "At-The-Market" Equity Offering 7/24/2015
Drugs Trump Tech As Investors Shift Earnings Bets To Healthcare 7/24/2015
BioLight Announces Upcoming Change Of ADS Conversion Ratio 7/23/2015
NephroGenex (NRX) Announces Closing Of Public Offering Of Common Stock And Warrants 7/23/2015
Integrity Applications, Inc. Announces Adjournment Of Annual Meeting 7/23/2015
Allergy Therapeutics plc: Notice of Results and Trading Update 7/23/2015
Abcam Inc.: Pre-Close Trading Update 7/23/2015
Discovery Laboratories (DSCO) Announces Completion of $40.25 Million Public Offering 7/23/2015
Pressure BioSciences, Inc. (BBII) Closes $2,180,000 Initial Tranche Of A $5 Million Private Placement 7/23/2015
Radius Health (RDUS) Announces Pricing Of Public Offering 7/23/2015
Mad Money’s Jim Cramer Wants Johnson & Johnson (JNJ) Busted Into Three Companies 7/22/2015
Flamel Technologies (FLML) Announces Results Of 2015 Annual Meeting; Domestic U.S. Public Company Reporting Status To Begin In 2016 7/22/2015
Motif Bio plc Release: Final Condition Of £22 Million Placing Satisfied With FDA QIDP Designation For iclaprim 7/22/2015
Exelixis (EXEL) Launches Proposed Public Offering Of Common Stock 7/22/2015
Dynavax Technologies Corporation (DVAX) Prices Public Offering Of Common Stock 7/22/2015
TrovaGene, Inc. Announces Closing Of Public Offering Of Common Stock 7/22/2015
ProNAi Therapeutics, Inc. Announces Closing Of IPO And Full Exercise Of The Underwriters' Option To Purchase Additional Shares 7/22/2015
RedHill Biopharma Ltd. (RDHL) Announces Closing Of Public Offering Of Its American Depository Shares 7/22/2015
Sunshine Heart Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 7/22/2015
Fibrocell Science, Inc. Announces Pricing Of Public Offering Of Common Stock 7/22/2015
Ultragenyx Pharmaceuticals (RARE) Announces Closing Of Public Offering Of Common Stock And Exercise Of Underwriters' Option To Purchase Additional Shares 7/22/2015
Achaogen (AKAO) Announces Employment Inducement Grants 7/22/2015
Fibrocell Science, Inc. Announces Proposed Public Offering Of Common Stock 7/22/2015
Radius Health (RDUS) Announces Proposed Public Offering 7/22/2015
NeuroDerm (NDRM) Announces Closing Of Public Offering And Full Exercise Of Underwriters' Option To Purchase Additional Shares 7/22/2015
Perimeter Medical Imaging Closes Oversubscribed $5 Million Series A Financing Round Led By Roadmap Capital 7/22/2015
Depomed (DEPO) Confirms Receipt Of Purported Revised, Highly Conditional, Unsolicited Proposal From Horizon Pharma (HZNP) 7/21/2015
Antibe Therapeutics Inc. (ATE.V) Announces Addition Of Aspirin Derivative To Its Product Pipeline And Provides An Update On Validation Studies 7/21/2015
CytRx Corporation (CYTR) Announces Proposed Public Offering Of Common Stock 7/21/2015
Protalex, Inc. (PRTX) Announces Listing On OTCQB Exchange 7/21/2015
Dauntless Pharmaceuticals Launches New Company Focused On Developing A Portfolio Of Improved Therapeutics 7/21/2015
Resverlogix (RVX.TO) Closes $50 Million Private Placement With Hepalink And Eastern Capital 7/21/2015
Horizon Pharma (HZNP) Increases Offer For Depomed (DEPO) To $33.00 Per Share 7/21/2015
CytRx Corporation (CYTR) Announces Pricing Of Public Offering Of 9.1 Million Shares Of Common Stock 7/21/2015
Synthetic Biologics, Inc. (SYN) Announces Closing Of Recent Equity Offering And Exercise In Full Of Underwriters' Over-Allotment Option 7/21/2015
EXACT Sciences (EXAS) Announces Pricing Of Public Offering Of Common Stock 7/21/2015
Polydex Pharmaceuticals (POLXF) Extends Invitation To AGM And Advises On Voting Procedures 7/21/2015
Secondary Placing Of Ordinary Shares In ErgoMed 7/20/2015
NuGene International Inc. Secures $301,450 Product Purchase Reorder From Leading Existing Distributor and Also Announces New Distributor With Initial Orders Exceeding $71,000 7/20/2015
NOVACYT Release: Strong First-Half Revenues Completes €3.5 Million In Bond Refinancing And Launches A €1.7 Million Private Placement 7/20/2015
TONIX Pharmaceuticals, Inc. (TNXP) Closes $20.1 Million Public Offering Of Common Stock 7/17/2015
Cleveland Biolabs Inc. (CBLI) Announces Receipt Of Letter From Nasdaq Confirming Compliance With Minimum Stockholders' Equity Requirement 7/17/2015
Thermo Fisher Scientific (TMO) Prices Offering Of Euro-Denominated Senior Notes 7/17/2015
Vermillion Announces Closing Of $18.8 Million Public Offering Of Common Stock 7/17/2015
NephroGenex (NRX) Prices $7,500,000 Public Offering 7/17/2015
RedHill Biopharma Ltd. (RDHL) Prices Public Offering Of Its American Depository Shares 7/17/2015
Discovery Laboratories (DSCO) Announces Proposed Public Offering Of Common Stock, Warrants And Pre-Funded Warrants 7/17/2015
HEALTHSOUTH Increases And Declares Dividend On Common Stock 7/17/2015
TrovaGene, Inc. Announces Public Offering Of Common Stock 7/17/2015
Immune Pharmaceuticals, Inc. Joins The Russell Microcap Index 7/17/2015
Delcath Systems (DCTH) Announces Pricing Of Public Offering 7/16/2015
NovaBay (NBY) Plan Of Compliance Accepted By NYSE 7/16/2015
Chiasma Prices Initial Public Offering Of Common Stock 7/16/2015
Synthetic Biologics, Inc. (SYN) Announces Pricing Of $40.0 Million Public Offering 7/16/2015
Ultragenyx Pharmaceuticals (RARE) Announces Pricing Of Public Offering Of Common Stock 7/16/2015
NeuroDerm (NDRM) Announces Pricing Of Public Offering 7/16/2015
ProNAi Therapeutics, Inc. Announces Pricing Of Initial Public Offering 7/16/2015
Synthetic Biologics, Inc. (SYN) Announces Public Offering Of Common Stock 7/16/2015
West Pharmaceutical Services Announces Increase To Quarterly Dividend 7/15/2015
SiteOne Therapeutics Secures Investment From Bozeman-Based Next Frontier Capital 7/15/2015
MediGene AG (MDGEF.PK): Notification § 27a 7/15/2015
Atara Biotherapeutics (ATRA) Announces Closing Of Underwritten Offering Of Common Stock And Full Exercise Of Underwriters' Option To Purchase Additional Shares 7/15/2015
Avacta Group plc Release: Conditional Placing To Raise Up To £22.0 Million 7/15/2015
BTG plc (BTG.L): Annual General Meeting 7/15/2015
Cynata Completes Private Placement To U.S. Institutional Investors 7/15/2015
RedHill Biopharma Ltd. (RDHL) Announces Size Of Proposed Public Offering Of Its American Depository Shares 7/15/2015
NewLink Genetics (NLNK) Shares Immuno-Oncology Vision At Investor Day 7/15/2015
BG Medicine (BGMD) Announces Payoff Of Secured Term Loan 7/15/2015
Akorn, Inc. (AKN) Announces Nasdaq's Acceptance Of Its Plan To Regain Compliance 7/15/2015
RedHill Biopharma Ltd. (RDHL) Announces Proposed Public Offering Of Its American Depository Shares 7/15/2015
Ultragenyx Pharmaceuticals (RARE) Announces Proposed Public Offering Of Common Stock 7/15/2015
GeneNews (GEN.TO) Announces Proposed Non-Brokered Private Placement 7/15/2015
Anthera Pharmaceuticals, Inc. (ANTH) Announces Completion Of Public Offering Of Common Stock And Exercise In Full Of Underwriters' Option To Purchase Additional Shares 7/14/2015
Extraordinary General Meeting In Aerocrine AB 7/14/2015
Summit Therapeutics Annual General Meeting Statement 7/14/2015
Intuitive Surgical (ISRG) Reports New Employee Option Grants For July 2015 7/14/2015
K2M Announces Closing Of Sale Of Shares Of Common Stock 7/14/2015
Aegerion (AEGR) Grants Stock Options Under Inducement Program 7/14/2015
TONIX Pharmaceuticals, Inc. (TNXP) Announces Proposed Public Offering Of Common Stock 7/14/2015
MacroGenics, Inc. (MGNX) Announces Proposed Public Offering Of Common Stock 7/14/2015
TONIX Pharmaceuticals, Inc. (TNXP) Prices Underwritten Public Offering Of Common Stock 7/14/2015
Vermillion Prices $16.4 Million Public Offering Of Common Stock 7/14/2015
Vermillion Announces Proposed Public Offering Of Common Stock 7/14/2015
Becton, Dickinson and Company (BDX) Announces Sustainability Goals For 2020 7/13/2015
Aethlon Medical (AEMD) Begins Trading On The Nasdaq Capital Market 7/13/2015
CureMark Secures $20 Million In Equity Financing 7/13/2015
Amarantus BioSciences, Inc. To Commence Trading On The OTCQX Marketplace Under Existing Ticker Symbol AMBS 7/13/2015
Concordia Healthcare (CXR.TO) Announces Filing of Preliminary Base Shelf Prospectus 7/13/2015
Young Biotechs' Stock Market Rollercoaster 7/13/2015
KaloBios Pharmaceuticals, Inc. (KBIO) Announces Shareholders And Board Of Directors Approval Of Reverse Stock Split 7/13/2015
Merus Labs International Inc. Announces Filing of Preliminary Base Shelf Prospectus 7/10/2015
Stellar Biotechnologies, Inc. Retains The Ruth Group To Advance Communications Objectives 7/10/2015
TherapeuticsMD, Inc.  (TXMD) Announces Pricing Of Common Stock Offering 7/10/2015
Clovis Oncology (CLVS) Announces Exercise In Full Of Underwriters’ Option To Purchase Additional Shares Of Common Stock 7/10/2015
Motif Bio Plc Release: Result Of General Meeting 7/10/2015
Thermo Fisher Scientific (TMO) Declares Quarterly Dividend 7/10/2015
Opko Health (OPK) Investee Scivac Announces The Completion Of Transaction With Levon Resources 7/10/2015
The Cooper Companies, Inc. (COO) Declares Cash Dividend 7/10/2015
StemCells (STEM) Clinical Programs Overview And Progress Update 7/10/2015
Atara Biotherapeutics (ATRA) Announces Pricing Of Its $180 Million Offering Of Common Stock 7/10/2015
PharmaCyte Biotech (NVLX) Appoints American Stock Transfer As New Stock Transfer Agent 7/10/2015
Urologix (ULGX) Announces SEC Deregistration 7/10/2015
Henry Schein, Inc. (HSIC) Invests In Romania's Maravet 7/10/2015
Hanger Inc. (Formerly known as Hanger Orthopedic Group, Inc.) (HGR) Announces The Successful Completion Of Senior Notes Consent Solicitation And Entry Into Supplemental Indenture 7/10/2015
EXCLUSIVE: New Report Says Biosimilars Will Earn $55B by 2020, As Pfizer (PFE), Actavis (ACT), AbbVie (ABBV) Claim U.S. Market 7/9/2015
Celgene (CELG) Paid $93 Per Share For Juno Therapeutics (JUNO), But You're Only Willing To Pay $50? 7/9/2015
Ampio Pharmaceuticals, Inc. (AMPE) Announces Investor Call On Thursday, July 16, 4:30 p.m. EDT 7/9/2015



//-->